XBI State Street SPDR S&P Biotech ETF
AMEXETFAs of 2026-08-24 16:00
Why XBI matters now
State Street SPDR S&P Biotech ETF (XBI) is a US etf in Financial Services. The latest InvestLog snapshot shows $164.17 with -0.94% on the session and $8.58B in assets/market value.
The latest indexable market news headline is "Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)?" from Zacks Investment Research.
ETF Profile
Updated 2026-08-25Net Assets
$11.52B
NAV
$165.68
Expense Ratio
0.35%
Holdings
155
Issuer
SPDR
Asset Class
Equity
Avg Volume
8,717,377
Inception
2006-01-31
Sector Exposure
Top Holdings
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| MRNA | MODERNA INC | 2.85% | $324.5M |
| TWST | TWIST BIOSCIENCE CORP | 1.94% | $220.9M |
| ORKA | ORUKA THERAPEUTICS INC | 1.52% | $173.4M |
| APGE | APOGEE THERAPEUTICS INC | 1.47% | $167.5M |
| PRAX | PRAXIS PRECISION MEDICINES I | 1.41% | $160.6M |
| HALO | HALOZYME THERAPEUTICS INC | 1.38% | $157.8M |
| NTRA | NATERA INC | 1.38% | $157.7M |
| KYMR | KYMERA THERAPEUTICS INC | 1.38% | $157.5M |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1.32% | $150.0M |
| DNTH | DIANTHUS THERAPEUTICS INC | 1.31% | $149.5M |
Latest News
Fund Info
Asset Type
ETF
Exchange
AMEX
Currency
USD
Issuer
SPDR
Asset Class
Equity
NAV Currency
USD
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.